HEALTH

AlcoMate awarded ECRM Home Health Care Best Product

BY Michael Johnsen

ATLANTA — AK GlobalTech last month was recognized with a Best Product of the Show Award for its AlcoMate SafeGuard (AL2500) at the ECRM Home Health Care EPPS here.

The AlcoMate SafeGuard is a portable, personal breathalyzer designed for home use. Selling for $49.99 on Walgreens.com, the device has been certified for use by law enforcement by the Department of Transportation and carries a U.S. Coast Guard Approved certification. The three-digit LED results display is backlit for nighttime use, and no mouthpieces are necessary.

ECRM’s Best Product of the Show Award, sponsored by DSN, represents the most talked about product at the show, according to votes taken from attending retail buyers. 


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Abbott launches Perfectly Simple by ZonePerfect

BY Michael Johnsen

ABBOTT PARK, Ill. — Abbott recently launched Perfectly Simple by ZonePerfect, a line extension that is gluten-free and features fewer ingredients in each bar (between six and 10 ingredients).

Shipping in April, Perfectly Simple by ZonePerfect is available in three flavors: peanut crunch, cranberry almond and toasted coconut. The nutrition bars contain 10 g of protein, with no preservatives or added coloring. Each bar contains between 170 and 200 calories.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Prestige Brands tells Mexican suitor ‘No mas’

BY Michael Johnsen

IRVINGTON, N.Y. — Prestige Brands on Thursday reiterated its rebuke of a buyout offer from Mexican healthcare supplier Genomma Lab Internacional following Genomma’s release of a proposal presentation.

"As we have previously stated and as we told Genomma and its advisers on April 5, should they make [a compelling] offer, there would be a basis to engage with them," Prestige stated. "However, Genomma’s offer has not changed, and has already been unanimously rejected by the Prestige board as being inadequate and opportunistic. Aside from the offer not being compelling, Genomma has not provided any evidence that it has obtained financing commitments."

“Prestige is committed to maximizing stockholder value and would be open to compelling offers that provide certainty of closing," the company said. "We remain open to meeting with Genomma should they put forward a compelling offer.”

In the presentation dated April 26, Genomma is making an all-cash offer of $16.60 per share, valued at $856 million.

As of mid-day trading Friday, Prestige Brands shares were trading down some 20 cents for the day to $17.14 per share.

Citing those April 5 discussions with Prestige, Genomma suggested it would take its offer directly to Prestige shareholders. Genomma is targeting Prestige Brands’ June 29 annual shareholder meeting to claim five Prestige directorships with Genomma nominees and vote to accept its $16.60-per-share acquisition offer.


Interested in this topic? Sign up for our weekly Collaborative Care e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES